Canada

Canada

HBV elimination goal
Yes
Year of HBV elimination goal
No data
HBV Action Plan
Yes
HCV elimination goal
Yes
Year of HCV elimination goal
No data
HCV Action Plan
Yes
Prevalence
Prevalence of chronic HBV (HBsAg+) (%)
0.6
2022 , Modelled
(0 - 1)
Razavi-Shearer D, Gamkrelidze I, Pan C, et al. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. The Lancet Gastroenterology & Hepatology. 2023;8(10):879-907. doi:10.1016/S2468-1253(23)00197-8
Prevalence of chronic HBV (HBsAg+), Children < 5 yrs
No data
Prevalence
Prevalence of chronic HCV (RNA+/cAg) (%)
0.54
2019 , Survey/reported
Popovic N, et al. National Hepatitis C estimates: Incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019. Can Commun Dis Rep. 2022 Nov 3;48(11-12):540-549.
Prevalence of chronic HCV (RNA+/cAg), Persons who inject drugs
No data
Mortality
HBV-related death rate (per 100,000)
1.22
2019 , Modelled
Institute of Health Metrics and Evaluation (IHME). Global burden of Disease Study 2019
Mortality
HCV-related death rate (per 100,000)
7.37
2019 , Survey/reported
Report on Hepatitis B and C Surveillance in Canada: 2019.
Diagnosed & treated
Proportion of persons living with HBV diagnosed (%)
71
2022 , Modelled
Razavi-Shearer D, Gamkrelidze I, Pan C, et al. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. The Lancet Gastroenterology & Hepatology. 2023;8(10):879-907. doi:10.1016/S2468-1253(23)00197-8
Proportion of diagnosed persons receiving appropriate HBV treatment (%) (among those eligible)
No data
Diagnosed & treated
Proportion of persons living with HCV diagnosed (%)
76
2019 , Survey/reported
Popovic N, Williams A, Perinet S, et al. National Hepatitis C estimates: Incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019. Can Commun Dis Rep. 2022;48(11-12):540-549. Published 2022 Nov 3
Proportion of diagnosed persons who have initiated HCV treatment (%)
No data
HepB newborn vaccination
Coverage of HepB birth dose (%)
No data
Harm reduction
Number of needles-syringes per PWID per year
291
2016 , Survey/reported
Action Hepatitis Canada. Progress Towards Viral Hepatitis Elimination By 2030 In Canada: 2021 Report. Toronto, ON. Available at:
Key policy indicators
HBV screening recommendations for pregnant women
Adopted
No patient co-pays for HBsAg testing
No Data
Key policy indicators
National policy for harm reduction for persons who inject drugs
Adopted
No patient co-pays for anti-HCV testing
Adopted
Simplified HCV care: Non-specialists can prescribe treatment
Not Adopted
Year Value Type Source
Equity
Indicator Status Notes
Decriminalization of drug use Not Adopted
Canada National Hepatitis Elimination Profile
National anti-discrimination law protecting persons living with hepatitis Partially Adopted
Canada National Hepatitis Elimination Profile
National policy for adult HBV vaccination Adopted
Canada National Hepatitis Elimination Profile
National policy for harm reduction for persons who inject drugs Adopted
Canada National Hepatitis Elimination Profile
National policy for syringe exchange in federal prisons Adopted
Canada National Hepatitis Elimination Profile
National strategy addresses key populations Adopted
Canada National Hepatitis Elimination Profile
Prevention of mother-to-child transmission
Indicator Status Notes
Elimination of HBV mother to child transmission goal Yes
Canada National Hepatitis Elimination Profile
HBV screening recommendations for pregnant women Adopted
Canada National Hepatitis Elimination Profile
Universal HepB birth dose policy within 24 hrs of birth Partially Adopted
Canada National Hepatitis Elimination Profile
Strategic information
Indicator Status Notes
Estimates of HBV economic burden Adopted
Canada National Hepatitis Elimination Profile
National HBV prevalence survey within last 5 years Adopted
Canada National Hepatitis Elimination Profile
Routine official reporting of HBV incidence Adopted
Canada National Hepatitis Elimination Profile
Routine official reporting of HBV mortality Not Adopted
Canada National Hepatitis Elimination Profile
System to monitor HBV diagnosis and treatment Partially Adopted
Canada National Hepatitis Elimination Profile
Financing
Indicator Status Notes
GFTAM funds used for HBV and/or HCV testing and treatment or harm reduction Not Applicable
Canada National Hepatitis Elimination Profile
Public budget line for HBV testing and treatment Adopted
Canada National Hepatitis Elimination Profile
National planning
Indicator Status Notes
HBV Action Plan Yes
Canada National Hepatitis Elimination Profile
HBV elimination goal Yes
Canada National Hepatitis Elimination Profile
Screening
Indicator Status Notes
HBV age-based or birth-cohort screening recommendations Adopted
Canada National Hepatitis Elimination Profile
HBV risk-based screening recommendations Adopted
Canada National Hepatitis Elimination Profile
HBV universal screening recommendations Not Adopted
Canada National Hepatitis Elimination Profile
No patient co-pays for HBsAg testing No Data
Canada National Hepatitis Elimination Profile
Access to testing and medicines
Indicator Status Notes
Licensed point-of-care PCR testing to detect HBV Not Adopted
Canada National Hepatitis Elimination Profile
Treatment
Indicator Status Notes
National HBV treatment guidelines No Data
Canada National Hepatitis Elimination Profile
Simplified HBV care: No treatment co-pays Adopted
Canada National Hepatitis Elimination Profile
Simplified HBV care: Treatment and monitoring algorithm for primary care providers No Data
Canada National Hepatitis Elimination Profile
Year Value Type Source
Year Value Type Source
Equity
Indicator Status Notes
Decriminalization of drug use Not Adopted
Canada National Hepatitis Elimination Profile
Decriminalization of possession of syringes and paraphernalia Adopted
Canada National Hepatitis Elimination Profile
National anti-discrimination law protecting persons living with hepatitis Partially Adopted
Canada National Hepatitis Elimination Profile
National policy for harm reduction for persons who inject drugs Adopted
Canada National Hepatitis Elimination Profile
National policy for syringe exchange in federal prisons Adopted
Canada National Hepatitis Elimination Profile
National strategy addresses key populations Adopted
Canada National Hepatitis Elimination Profile
Access to testing and medicines
Indicator Status Notes
Eligible for HCV generic medicines Not Eligible
Canada National Hepatitis Elimination Profile
Licensed point-of-care PCR testing to detect HCV Not Adopted
Canada National Hepatitis Elimination Profile
Registration of HCV generic medicines Not Applicable
Canada National Hepatitis Elimination Profile
Registration of HCV originator medicines Adopted
Canada National Hepatitis Elimination Profile
Strategic information
Indicator Status Notes
Estimates of HCV economic burden Adopted
Canada National Hepatitis Elimination Profile
National HCV prevalence survey within last 5 years Adopted
Canada National Hepatitis Elimination Profile
Routine official reporting of HCV incidence Adopted
Canada National Hepatitis Elimination Profile
Routine official reporting of HCV mortality Not Adopted
Canada National Hepatitis Elimination Profile
System to monitor HCV diagnosis and treatment Partially Adopted
Canada National Hepatitis Elimination Profile
Financing
Indicator Status Notes
GFTAM funds used for HBV and/or HCV testing and treatment or harm reduction Not Applicable
Canada National Hepatitis Elimination Profile
Public budget line for HCV testing and treatment Adopted
Canada National Hepatitis Elimination Profile
National planning
Indicator Status Notes
HCV Action Plan Yes
Canada National Hepatitis Elimination Profile
HCV elimination goal Yes
Canada National Hepatitis Elimination Profile
Screening
Indicator Status Notes
HCV age-cohort or birth-cohort screening recommendations Not Adopted
Canada National Hepatitis Elimination Profile
HCV risk-based screening recommendations Adopted
Canada National Hepatitis Elimination Profile
HCV universal screening recommendations Not Adopted
Canada National Hepatitis Elimination Profile
No patient co-pays for anti-HCV testing Adopted
Canada National Hepatitis Elimination Profile
Prevention of mother-to-child transmission
Indicator Status Notes
HCV screening recommendations for pregnant women Partially Adopted
Canada National Hepatitis Elimination Profile
Treatment
Indicator Status Notes
National HCV treatment guidelines Developed
Canada National Hepatitis Elimination Profile
Simplified HCV care: Less than 2 clinic visits during treatment Adopted
Canada National Hepatitis Elimination Profile
Simplified HCV care: No fibrosis restrictions Partially Adopted
Canada National Hepatitis Elimination Profile
Simplified HCV care: No genotyping requirements Partially Adopted
Canada National Hepatitis Elimination Profile
Simplified HCV care: No sobriety restrictions Adopted
Canada National Hepatitis Elimination Profile
Simplified HCV care: No treatment co-pays Partially Adopted
Canada National Hepatitis Elimination Profile
Simplified HCV care: Non-specialists can prescribe treatment Not Adopted
Canada National Hepatitis Elimination Profile
Year Value Type Source
Page last updated: 31 January 2024